Introduction
============

Body mass index (BMI), calculated from the height and weight of a patient, is a simple and useful index for obesity[@B1]. BMI has been reported to be an important prognostic factor for many medical conditions. For example, in chronic obstructive pulmonary disease, chronic renal failure, and cancer, mortality is increased in underweight patients[@B2][@B3], whereas in many metabolic diseases, including hypertension, diabetes mellitus, and dyslipidemia, mortality is commonly increased in overweight patients[@B4]. Moreover, the relationship between BMI and all-cause mortality in the general population is known to be 'J'- or 'U'-shaped[@B5].

Many studies have examined the usefulness of BMI as a prognostic factor in critically ill patients with differing results. Mortality appears to be increased in morbidly obese patients[@B6], while no relationship between mortality and obesity was observed in another prospective study[@B7]. Moreover, recent studies have shown that mortality in the intensive care unit (ICU) is lower in obese patients than in those who are underweight[@B7][@B8][@B9]. The development of acute kidney injury (AKI) in ICU patients is a frequent complication that can affect the prognosis[@B10][@B11]. Therefore, the development of AKI in these patients and the associated risk factors have been extensively studied[@B11]. However, only a few studies have assessed the relationship between BMI and AKI in critically ill patients[@B12][@B13][@B14][@B15]. Accordingly, the purpose of this study was to assess the influence of BMI on the development of AKI in critically ill patients.

Materials and Methods
=====================

1. Study design and settings
----------------------------

All critical-ill patients who were admitted to the medical intensive care unit (MICU) at Gyeongsang National University Hospital (hospital total, 890 beds; MICU, 13 to 15 beds) between December 2011 and May 2014 were retrospectively studied. The admission was decided by attending physician according to general criteria of ICU admission[@B16]. Before admission, consents were received from patients\' family or caregiver. Patients were excluded if they were admitted for acute coronary syndrome, overdose, acute cerebrovascular disease, and chronic renal failure or were \<18 years of age.

This study was approved by the institutional review board of Gyeongsang National University Changwon Hospital (GNUCH-2018-05-014). Informed consent was waived due to the retrospective nature of the study.

2. Data collection and definitions
----------------------------------

Demographic information, past medical history, and reason for ICU admission were collected for each patient on admission and discharge from the MICU according to the MICU registry at our institution. The Acute Physiology and Chronic Health Evaluation (APACHE) II score and Sequential Organ Failure Assessment (SOFA) score, measures of severity of illness and predictors of mortality[@B17], were also calculated. Height was recorded based on previous medical records or the ICU admission measurement. Body weight was measured automatically using a calibrated bed scale (VersaCare Bed; Hill-Rom, Batesville, IN, USA) at ICU admission. BMI was calculated as body weight (kg)/height (m^2^). The patients were classified into three groups based on the degree of obesity as defined by the World Health Organization and the National Heart, Lung and Blood Institute of the National Institutes of Health as follows: underweight (BMI, \<18.5 kg/m^2^), normal (BMI, 18.5--24.9 kg/m^2^), and overweight (BMI, ≥25.0 kg/m^2^) groups[@B18].

AKI was defined by the Risk, Injury, Failure, Loss of kidney function, and End-stage (RIFLE) kidney disease criteria using the creatinine level, glomerular filtration rate, and urine output[@B19]. The number of days the patient required mechanical ventilation, length of stay (LOS) in the ICU and hospital, and mortality in the ICU and hospital were assessed.

3. Statistical analysis
-----------------------

Continuous variables are reported as the mean±standard deviation. Categorical variables are described as number (%). Differences between groups were compared using analysis of variance, Student\'s t test, or chi-square test as appropriate. Univariate and multivariate logistic regression analysis was performed to examine the relation between BMI and the factors associated with the development of AKI. Statistical significance was defined as a p-value of \<0.05. All data were analyzed using SPSS version 22.0 for Windows (IBM Corp., Armonk, NY, USA).

Results
=======

1. Patient characteristics
--------------------------

A total of 468 patients were analyzed. The average age was 68.6±13.9 years, with a male-to-female ratio of 2:1. The mean BMI was 21.5±3.9 kg/m^2^ (range, 12.2--39.6 kg/m^2^). The mean APACHE II and SOFA scores were 18.8±8.8 and 7.9±4.4, respectively. The average LOS was 10.0±18.1 days in the ICU and 25.7±35.8 days in the hospital. The ICU morality rate was 35.8%, with an overall hospital mortality rate of 44.7%. AKI developed in 82 patients (17.1%).

2. Comparison of clinical characteristics according to the BMI groups
---------------------------------------------------------------------

The baseline characteristics of the patients according to BMI group are summarized in [Table 1](#T1){ref-type="table"}. Of the 468 patients, 102 (21.8%) were underweight, 286 (61.1%) were normal-weight, and 80 (17.1%) were overweight. The mean age of the underweight group was 71.3±12.7 years, which was significantly older than that of the overweight patients (64.9±13.8 years, p=0.008). For the underweight, normal-weight, and overweight groups, the mean BMI values were 16.5±1.5, 21.6±1.8, and 27.7±2.5 kg/m^2^, respectively. The overweight group had a significantly higher incidence of AKI (36.3%) than the underweight (9.8%) and normal groups (15.0%) (p\<0.001 for all). In addition, the overweight group had a higher incidence of hypertension, liver cirrhosis, and chronic kidney disease (p\<0.05 for all). The diagnoses on admission included septic shock, acute respiratory distress syndrome (ARDS), gastrointestinal bleeding, with septic shock and ARDS being the main reasons for admission to the MICU. The established causes of septic shock and ARDS were described in the [Table 1](#T1){ref-type="table"}. Compared to the underweight (27.5%) and normal (33.9%) groups, the overweight group had a significantly higher incidence of septic shock (46.2%) as the reason for ICU admission (p=0.010). The APACHE II and SOFA scores of the overweight group were also significantly higher than those of the other two groups (p=0.002 and p\<0.001, respectively). Regarding the clinical outcomes, the LOS in the ICU and hospital tended to be shorter when the BMI was increased. The highest mortality was found in the overweight group, and the lowest mortality was found in the normal weight group. However, there were no significant differences among the three BMI groups regarding the ICU LOS, hospital LOS, ICU death rate, and in-hospital death rate (p\>0.05 for all).

3. Comparison of clinical characteristics according to development of AKI
-------------------------------------------------------------------------

The BMI was significantly higher in patients with AKI than in those without it (23.4±4.2 kg/m^2^ vs. 21.1±3.7 kg/m^2^, p\<0.05). Patients with AKI had a higher incidence of liver cirrhosis, diabetes, chronic kidney disease, and alcoholism. Moreover, these patients showed a higher incidence of septic shock and ARDS than patients without AKI at the time of admission. Extubation failure, need for transfusion, use of renal replacement therapy, and application of extracorporeal membrane oxygenation were also more common in patients with AKI than in those without it. Regarding the clinical outcomes, the LOS in the ICU and hospital were significantly longer for patients with AKI than for those without AKI (p\<0.05). The ICU and hospital mortality rates were also significantly higher in patients with AKI than in those without it (74.4% vs. 30.8% for ICU mortality; 74.4% vs. 38.3% for hospital mortality; p\<0.05 for both) ([Table 2](#T2){ref-type="table"}).

4. Risk factors for development of AKI
--------------------------------------

Finally, we assessed the risk factors for AKI in the ICU by logistic regression analyses. In univariate analysis, BMI, diabetes, chronic kidney disease, liver cirrhosis, alcoholism, septic shock, ARDS, SOFA score, and APACHE II score were found to be risk factors for AKI. However, BMI groups were found to be significantly associated with a risk of developing AKI in the multivariate analysis (odds ratio, 1.893; 95% confidence interval, 1.224--2.927; p=0.004) ([Table 3](#T3){ref-type="table"}).

Discussion
==========

This study revealed that BMI was an independent risk factor for the development of AKI in critically ill patients.

Although BMI has been shown to be a useful prognostic marker in critically ill patients, the relationship between BMI and the development of AKI has not been extensively investigated in the literature[@B12][@B13][@B14][@B15]. However, several reports investigated the association between BMI and the development of AKI in critically ill patients. Soto et al.[@B13] retrospectively analyzed risk factors for AKI in 751 patients with ARDS. The study showed that the prevalence of AKI increased significantly with increasing weight. In addition, there was a 2-fold increase in the risk of AKI in obese patients compared to those of normal weight. The study also reported that the risk could not be completely explained by the severity of illness. A study of 390 patients with sepsis also showed that BMI was higher in patients with AKI than in patients without AKI[@B15]. Another study showed the incidence of AKI in patients requiring renal replacement therapy went up as BMI increased[@B12]. Further, several studies have reported that AKI develops more frequently in patients with a high BMI after cardiac and abdominal surgery[@B20][@B21]. These findings, along with our study, showed that a high BMI was a risk factor for the development of AKI in critically ill patients.

The association between high BMI and risk of AKI development could be explained by several mechanisms. First, obesity causes some hemodynamic changes in the glomerulus such as glomerular hyperperfusion and hyperfiltration due to impaired natriuresis-associated activation of the renin and angiotensin system. Glomerular hyperperfusion and hyperfiltration may be result in glomerular injury. These changes have been demonstrated in an experimental animal model of obesity and in obese patients[@B22][@B23]. Second, obesity can increase the hemodynamic and metabolic load on each individual glomerulus, which results in a low number of functional nephrons in obese patients[@B24]. In turn, a low number of functional nephrons was related to glomerular hypertrophy and glomerulosclerosis due to increased capillary pressure on the remaining functional nephrons[@B24]. Third, adipocytes may be as a production site for activated inflammatory cytokines and oxidative stress in obese patients[@B25]. Increased oxidative stress can contribute to detrimental changes in the glomeruli[@B26]. Taken together, in obese type II diabetes mellitus patients, reduction of body weight has been shown to be associated with significant decreases in proteinuria. This finding support that harmful influence of obesity to kidney injury[@B27].

Liver cirrhosis and diabetes were more common in patients with AKI than in patients without AKI in our study. In patients with liver cirrhosis, the development of AKI has been shown a relatively frequent problem, especially in critically ill patients, and it has a great impact on prognosis in these patients[@B28]. Although diabetes and the development of AKI was not studied in critically ill patients, a recent report showed that, in patients with sepsis, underlying diabetes was not associated with the development of AKI[@B29]. Further study is needed to evaluate diabetes as a risk factor for AKI in critically ill patients.

Extubation failure was more common in patients with AKI than in patients without AKI in our study. Extubation failure is usually associated with a longer duration of mechanical ventilation and ICU stay[@B30]. It may increase the risk of several complications in the ICU. As a result, ICU patients with extubation failure may be more vulnerable to developing AKI. Previous reports have showed that the time to extubation may be associated with development of AKI in postcardiac surgery patients[@B31][@B32]. These reports suggest that the duration of positive pressure ventilation in critically ill patients is an important risk factor for AKI development. In fact, mechanical ventilation itself has been shown to induce proinflammatory reactions and extrapulmonary end organ injury in animal models of mechanical ventilation[@B33][@B34]. Conversely, AKI may be associated with a higher rate of extubation failure and delayed weaning.

Although there are conflicting results between BMI and mortality in ICU patients. It is generally reported that patients with Low BMI have a higher mortality rate than those with normal BMI. A large-population prospective study conducted in Korea showed that low BMI patients has a higher mortality than in patient with normal and higher BMI[@B35]. In this study, the mortality rate of patients with low BMI was slightly higher (36% vs. 40%) than the patients with normal BMI although there was no statistically significant in two group.

There are some limitations to this study. First, enrolled patients came from the medical ICU of a single tertiary hospital. The risk factors for AKI in the MICU may differ from those in surgical ICUs. For example, in surgical ICU patients, postoperative AKI due to decreased intravascular volume is a relatively common problem. By contrast, the risk factors for AKI in MICU patients usually include the presence of infection and medications (e.g., antibiotics, vasopressors). Second, the characteristics of the enrolled patients were heterogeneous. Hence, the risk for AKI may be quite different and it depend on the underlying disease and the reason for ICU admission. Therefore, the risk factors for AKI are assessed in a homogenous group of patients such as sepsis or acute lung injury.

In conclusion, compared to low or normal BMI, a high BMI was found to be associated with a higher risk of developing AKI in critically ill patients treated in the MICU in this study. This result suggests that BMI may be associated with the development of AKI in critically ill patients.
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###### Baseline characteristics of patients by BMI groups

![](trd-81-311-i001)

  Characteristic                                 Total        Underweight (BMI \<18.5)   Normal (BMI 18.5--24.9)   Overweight (BMI ≥25.0)   p-value
  ---------------------------------------------- ------------ -------------------------- ------------------------- ------------------------ ---------
  No. of patients                                486          102                        286                       80                       
  Sex (male/female)                              306/162      62/40                      197/89                    47/33                    0.132
  Age, yr                                        68.6±13.9    71.3±12.7                  68.6±14.1                 64.9±13.8                0.008
  Age \>80 yr                                                 31 (30.4)                  62 (21.7)                 13 (16.3)                0.020
  BMI, kg/m^2^                                   21.5±3.9     16.5±1.5                   21.6±1.8                  27.7±2.5                 \<0.001
  AKI                                            82 (17.1)    10 (9.8)                                             29 (36.3)                \<0.001
  Comorbidities                                                                                                                             
   DM                                            155 (33.1)   27 (26.5)                  94 (33.0)                 34 (42.5)                0.074
   HTN                                           192 (41.0)   34 (33.3)                                            44 (55.0)                0.011
   CVD                                           89 (19.0)    25 (24.5)                  47 (16.4)                 17 (21.3)                0.174
   LC                                            45 (9.6)     3 (2.9)                    29 (10.1)                 13 (16.3)                0.009
   CKD                                           69 (14.7)    8 (7.8)                    42 (14.7)                 19 (23.8)                0.011
   Malignancy                                    59 (12.6)    15 (14.7)                  32 (11.2)                 12 (15.0)                0.510
   Heart failure                                 23 (4.9)     6 (5.9)                    15 (5.2)                  2 (2.5)                  0.530
   Alcoholism                                    70 (15)      10 (9.8)                   46 (16.1)                 14 (17.5)                0.510
  Reason for admission                                                                                                                      
   Severe sepsis/Septic shock                    162 (34.6)   28 (27.5)                  97 (33.9)                 37 (46.2)                0.010
    Lower respiratory tract infection            84 (17.9)    15 (14.7)                  56 (19.6)                 13 (16.3)                
    Gastrointestinal tract infection             10 (2.1)     0 (0)                      5 (1.7)                   5 (6.3)                  
    Urinary tract infection                      8 (1.7)      3 (2.9)                    4 (1.4)                   1 (1.3)                  
   Hepatobiliary tract infection                 5 (1.1)      1 (1.0)                    2 (0.7)                   2 (2.5)                  
   Intra-abdominal infection                                  0 (0)                      1 (0.3)                   1 (1.3)                  
   Wound infection                               2 (0.4)      1 (1.0)                    1 (0.3)                   0 (0)                    
   Mediastinal infection                         1 (0.2)      0 (0)                      0 (0)                     1 (1.3)                  
   Unknown                                                    8 (7.8)                    28 (9.8)                  14 (17.5)                
   ARDS                                          73 (15.6)    12 (11.8)                  44 (15.4)                 17 (21.3)                0.213
    Pulmonary cause                              60 (12.8)    8 (7.8)                    39 (13.6)                 13 (16.3)                
    Extrapulmonary cause                                      4 (3.9)                    5 (1.7)                   4 (5.0)                  
  APACHE II score                                18.8±8.8     16.7±7.5                   18.8±8.8                  21.4±10.0                0.002
  SOFA score                                     7.9±4.4      6.6±4.2                    7.9±4.2                   9.4±5.0                  \<0.001
  Extubation failure                             115 (24.6)   34 (33.3)                  63 (22.0)                 18 (22.5)                0.067
  Transfusion requirement                                     36 (35.3.7)                104 (36.4)                39 (48.8)                0.103
  Renal replacement therapy                      113 (24.1)   19 (18.6)                  66 (23.1)                 28 (35)                  0.030
  ECMO                                           8 (1.7)      0 (0)                      3 (1)                     5 (6.3)                  0.011
  Use of systemic steroid before ICU admission   87 (18.6)    27 (26.5)                  50 (17.5)                 10 (12.5)                0.041
  MV duration, day                               9.6±16.9     10.7±11.8                  9.8±19.8                  7.4±10.5                 0.412
  ICU LOS, day                                   10.0±18.1    11.7±13.4                  10.3±21.0                 6.9±9.8                  0.184
  Hospital LOS, day                                           28.3±39.2                  26.6±37.5                 19.2±22.2                0.186
  ICU death                                      180 (38.5)   41 (40.2)                                            35 (43.8)                0.448
  Hospital death                                 209 (44.7)   48 (47.1)                  121 (42.3)                40 (50.0)                0.406

Values are presented as mean±SD or number (%).

AKI: acute kidney injury; BMI: body mass index; DM: diabetes mellitus; HTN: hypertension; CVD: cardiovascular disease; LC: liver cirrhosis; CKD: chronic kidney disease; ARDS: acute respiratory distress syndrome; APACHE: Acute Physiology and Chronic Health Evaluation; SOFA: Sequential Organ Failure Assessment; ECMO: extracorporeal membrane oxygenation; ICU: intensive care unit; MV: mechanical ventilation; LOS: length of stay.

###### Baseline characteristics according to development of AKI
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  Characteristic                                 AKI         No AKI       p-value
  ---------------------------------------------- ----------- ------------ ---------
  No. of patients                                82          386          
  Sex (male/female)                              54/28       252/134      0.105
  Age, yr                                        66.3±13.9   69.1±13.8    0.105
  Age \>80 yr                                    14 (17.1)   98 (23.8)    0.185
  BMI, kg/m^2^                                   23.4±4.2    21.1±3.7     \<0.001
  Comorbidity                                                             
   DM                                            36 (43.9)   119 (30.8)   0.028
   HTN                                           38 (46.3)   154 (39.9)   0.323
   CVD                                           7 (8.5)     50 (13.0)    0.352
   LC                                            17 (20.7)   28 (7.3)     0.001
   CKD                                           8 (7.8)     42 (14.7)    0.011
   Malignancy                                    13 (15.9)   46 (11.9)    0.359
   Heart failure                                 6 (7.3)     17 (4.4)     0.264
   Alcoholism                                    21(25.6)    49 (12.7)    0.006
  Reason for admission                                                    
   Septic shock                                  43 (53.8)   119 (31.2)   \<0.001
    Lower respiratory tract infection            17 (20.7)   67 (17.4)    
    Gastrointestinal tract infection             7 (8.5)     3 (3.7)      
    Urinary tract infection                      3 (3.7)     5 (3.7)      
   Hepatobiliary tract infection                 2 (2.4)     3 (3.7)      
   Intra-abdominal infection                     2 (2.4)     0 (0)        
   Wound infection                               0 (0)       2 (0.5)      
   Mediastinal infection                         0 (0)       1 (0.3)      
   Unknown                                       12 (14.6)   38 (9.8)     
   ARDS                                          20 (24.4)   53 (13.7)    0.019
    Pulmonary cause                              15 (18.3)   45 (11.7)    
    Extrapulmonary cause                         5 (6.1)     8 (2.1)      
  RIFLE criteria                                                          
   Injury                                        63 (76.8)                
   Failure                                       19 (23.2)                
  APACHE II score                                23.5±8.6    17.8±8.6     \<0.001
  SOFA score                                     10.5±4.4    7.3±4.2      \<0.001
  Extubation failure                             33 (40.2)   82 (21.2)    0.001
  Transfusion requirement                        58 (70.7)   121 (31.3)   0.000
  Renal replacement therapy                      40 (48.8)   73 (18.9)    0.000
  ECMO                                           5 (6.1)     3 (0.8)      0.003
  Use of systemic steroid before ICU admission   14 (17.1)   73 (18.9)    0.750
  MV duration, day                               6.9±7.0     10.2±18.4    0.009
  ICU LOS, day                                   7.7±8.5     10.5±19.5    0.040
  Hospital LOS, day                              19.5±22.0   27.1±38.0    0.082
  ICU death                                      61 (74.4)   119 (30.8)   0.000
  Hospital death                                 61 (74.4)   148 (38.3)   0.000

BMI: body mass index; AKI: acute kidney injury; DM: diabetes mellitus; HTN: hypertension; CVD: cardiovascular disease; LC: liver cirrhosis; CKD: chronic kidney disease; ARDS: acute respiratory distress syndrome; RIFLE: Risk, Injury, Failure, Loss of kidney function, and End-stage kidney disease APACHE: Acute Physiology and Chronic Health Evaluation; SOFA: Sequential Organ Failure Assessment; ECMO: extracorporeal membrane oxygenation; ICU: intensive care unit; MV: mechanical ventilation; LOS: length of stay.

###### Univariate and multivariate logistic regression analysis for factor associated with development of AKI
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                  Univariate analysis   Multivariate analysis                                                                                  
  --------------- --------------------- ----------------------- ---------------------- --------- -------------- ------- ---------------------- -------
  Age \>80 yr     −0.419±0.317          1.746                   0.658 (0.354--1.224)   0.186     −0.086±0.351   0.060   0.917 (0.461--1.825)   0.917
  BMI, 3 groups   0.911±0.208           19.097                  2.486 (1.652--3.740)   \<0.001   0.638±0.222    8.223   1.893 (1.224--2.927)   0.004
   DM             0.559±0.248           5.071                   1.749 (1.075--2.846)   0.024     0.454±0.275    2.722   1.575 (0.918--2.701)   0.099
   LC             1.207±0.336           12.928                  3.344 (1.732--6.457)   0.000     0.415±0.416    0.999   1.515 (0.671--3.421)   0.317
   CKD            0.752±0.258           8.453                   2.210 (1.278--3.519)   0.004     0.223±0.296    0.567   1.250 (0.699--3.421)   0.451
  Alcoholism      −0.086±0.296          8.501                   0.422 (0.237--0.754)   0.004     −0.040±0.373   1.171   0.668 (0.321--1.387)   0.279
  Septic shock    0.470±0.126           13.971                  1.600 (1.250--2.047)   0.000     0.202±0.144    1.963   1.224 (0.337--1.431)   0.161
   ARDS           0.706±0.297           5.671                   2.027 (1.133--3.625)   0.017     0.624±0.325    3.683   1.866 (0.987--3.350)   0.055
   SOFA           0.161±0.029           31.672                  1.175 (1.111--1.242)   0.000     0.077±0.047    1.634   1.080 (0.985--1.183)   0.201

p-values less than 0.05 were considered as significant.

AKI: acute kidney injury; SE: standard error; CI: confidence interval; BMI: body mass index; DM: diabetes mellitus; LC: liver cirrhosis; CKD: chronic kidney disease; ARDS: acute respiratory distress syndrome; SOFA: Sequential Organ Failure Assessment.
